Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.46 is 66% above its 5-year average of -7.20, near the high end of its 5-year range (-13.01–-0.06).
68.46% above its 12-month average of -7.80.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.75.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 17 comparable quarters.
EARNINGS PER SHARE (EPS)
-2.46
EARNINGS PER SHARE (EPS) AVG TTM
-7.80
EARNINGS PER SHARE (EPS) AVG 3Y
-9.74
EARNINGS PER SHARE (EPS) AVG 5Y
-7.20
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+68.46%
CURRENT VS 3Y AVG
+74.74%
CURRENT VS 5Y AVG
+65.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Pasithea Therapeutics Corp.
Market Cap
$15.04M
Earnings Per Share (EPS)
-2.46
TTM Avg
-7.80
3Y Avg
-9.74
5Y Avg
-7.20
Market Cap
$15.44M
Earnings Per Share (EPS)
-0.77
TTM Avg
-1.25
3Y Avg
-1.82
5Y Avg
-1.86
Market Cap
$15.91M
Earnings Per Share (EPS)
-0.78
TTM Avg
-8.29
3Y Avg
-9461.74
5Y Avg
-302593.36
Market Cap
$14.44M
Earnings Per Share (EPS)
-13.07
TTM Avg
-13.67
3Y Avg
-19.10
5Y Avg
-23.67
Market Cap
$15.88M
Earnings Per Share (EPS)
-0.76
TTM Avg
-2.06
3Y Avg
-5.59
5Y Avg
-9.29
Market Cap
$13.99M
Earnings Per Share (EPS)
-2.11
TTM Avg
-3.38
3Y Avg
-4.90
5Y Avg
-6.31
Market Cap
$13.94M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.72M
Earnings Per Share (EPS)
-29.90
TTM Avg
-175.25
3Y Avg
-40254.86
5Y Avg
-180507.78
Market Cap
$13.62M
Earnings Per Share (EPS)
-1.87
TTM Avg
-10.75
3Y Avg
-23.11
5Y Avg
-21.98
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | $15.04M | -2.46 | -7.80 | -9.74 | -7.20 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.44M | -0.77 | -1.25 | -1.82 | -1.86 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -0.78 | -8.29 | -9461.74 | -302593.36 |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.44M | -13.07 | -13.67 | -19.10 | -23.67 |
| BioCardia, Inc. (BCDA)vs › | $15.88M | -0.76 | -2.06 | -5.59 | -9.29 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.99M | -2.11 | -3.38 | -4.90 | -6.31 |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.94M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | -29.90 | -175.25 | -40254.86 | -180507.78 |
| IN8bio, Inc. (INAB)vs › | $13.62M | -1.87 | -10.75 | -23.11 | -21.98 |
| Dyadic International, Inc. (DYAI)vs › | $16.85M | -0.21 | -0.22 | -0.25 | -0.30 |
Trailing EPS (TTM)
$-2.46
Forward EPS (Est.)
$-0.76
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.91 |
| 2024-12-31 | -12.69 |
| 2023-12-31 | -13.01 |
| 2022-12-31 | -10.34 |
| 2021-12-31 | -4.20 |
| 2020-12-31 | -0.06 |
